A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis
- PMID: 2459166
- DOI: 10.1016/s0190-9622(88)70207-8
A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis
Abstract
We investigated the effects of 1,25-dihydroxyvitamin D3 (1,25-(OH)2-D3) on cultured fibroblasts and keratinocytes from patients with psoriasis and treated 17 patients with psoriasis with orally or topically administered 1,25-(OH)2-D3. Cultured fibroblasts from three of five patients showed a normal response to the antiproliferative activity of a physiologic dose of 1,25-(OH)2-D3, whereas fibroblasts from the other two had a partial resistance to the drug. Cultured keratinocytes from two patients with psoriasis possessed nuclear receptors for 1,25-(OH)2-D3 and the drug caused a dose-dependent inhibition of proliferation and induction of terminal differentiation of these cells similar to effects in normal cultured keratinocytes. Ten of 14 patients with moderate to severe psoriasis who received oral 1,25-(OH)2-D3 showed significant clearing of their hyperkeratotic plaques. Three patients had complete clearing that was sustained with maintenance therapy, but four patients received little or no benefit from the therapy. By the administration of 1,25-(OH)2-D3 as a single oral dose at bedtime, larger doses of the drug could be tolerated without evidence of hypercalciuria or hypercalcemia. Three patients who received topical 1,25-(OH)2-D3 showed a rapid response with complete clearing after 6 weeks of therapy. Therefore, these preliminary findings suggest that orally or topically administered 1,25-(OH)2-D3 may be a safe and effective alternative therapy for the treatment of psoriasis.
Similar articles
-
Efficacy of vitamin D3 derivatives in the treatment of psoriasis vulgaris: a preliminary report.Mayo Clin Proc. 1993 Sep;68(9):835-41. doi: 10.1016/s0025-6196(12)60690-9. Mayo Clin Proc. 1993. PMID: 8396699
-
Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.Acta Derm Venereol. 1995 Sep;75(5):381-5. doi: 10.2340/0001555575381385. Acta Derm Venereol. 1995. PMID: 8615058 Clinical Trial.
-
Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.Br J Dermatol. 2000 Jul;143(1):72-8. doi: 10.1046/j.1365-2133.2000.03593.x. Br J Dermatol. 2000. PMID: 10886138
-
Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis.Arch Dermatol. 1987 Dec;123(12):1677-1683a. Arch Dermatol. 1987. PMID: 2825606 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases.Int J Mol Sci. 2022 Aug 29;23(17):9784. doi: 10.3390/ijms23179784. Int J Mol Sci. 2022. PMID: 36077185 Free PMC article. Review.
-
Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy.Int J Mol Sci. 2022 Aug 2;23(15):8575. doi: 10.3390/ijms23158575. Int J Mol Sci. 2022. PMID: 35955731 Free PMC article. Review.
-
Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives.Psoriasis (Auckl). 2022 Jun 22;12:151-176. doi: 10.2147/PTT.S328581. eCollection 2022. Psoriasis (Auckl). 2022. PMID: 35769285 Free PMC article. Review.
-
Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of Vitamin D3 According to the "Coimbra Protocol".Nutrients. 2022 Apr 10;14(8):1575. doi: 10.3390/nu14081575. Nutrients. 2022. PMID: 35458137 Free PMC article.
-
Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications.Nutrients. 2021 Apr 29;13(5):1511. doi: 10.3390/nu13051511. Nutrients. 2021. PMID: 33947070 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical